DeepMind-born drug discovery company Isomorphic Labs in funding talks at a $40-50 billion valuation
Isomorphic Labs, the DeepMind-born AI drug discovery company, is in early talks to raise money at a valuation of at least $40 billion, Bloomberg reported.